Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma

Cell Biology International

Volumn 36, Issue 5, 2012, Pages 427-432

  Li, Zhiqin ^a   Zhang, Hongyan ^a   Yang, Jianping ^a   Hao, Tielai ^a   Li, Shenglei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

DNA damage response genes; Hepatocellular carcinoma (HCC); Promoter hypermethylation

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE P1; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; ARTICLE; CANCER GRADING; CHECKPOINT WITH FORKHEAD AND RING FINGER DOMAIN GENE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GLUTATHIONE S TRANSFERASE P1 GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MUTL HOMOLOGUE GENE; O 6 METHYLGUANINE DNA METHYLTRANSFERASE GENE; ONCOGENE; POSTTRANSCRIPTIONAL GENE SILENCING; PROMOTER REGION; RAS ASSOCIATION DOMAIN FAMILY 1A GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AZACITIDINE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLUTATHIONE S-TRANSFERASE PI; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 84862499187     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100851     Document Type: Article

References (27)

1. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001;20:1509-18.
2. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001;93:691-9.
3. Chan KC, Lai PB, Mok TS, Chan HL, Ding C, Yeung SW et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem 2008;54:1528-36.
4. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004;127:1372-80.
5. Di Gioia S, Bianchi P, Destro A, Grizzi F, Malesci A, Laghi L et al. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. BMC Cancer 2006;6:89.
6. De Jong WK, Verpooten GF, Kramer H, Louwagie J, Groen HJ. Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer. Anticancer Res 2009;29:363-9.
7. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:S27-34.
8. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007;16:R50-9.
9. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-7.
10. Hibi K, Goto T, Mizukami H, Kitamura Y, Sakata M, Saito M et al. MGMT gene is aberrantly methylated from the early stages of colorectal cancers. Hepatogastroenterology 2009a;56:1642-4.
11. Hibi K, Sakata M, Yokomizo K, Kitamura YH, Sakuraba K, Shirahata A et al. Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma. Anticancer Res 2009b;29:5053-55.
12. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994;91:11733-7.
13. Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T et al. Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene 2002;21:2328-33.
14. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
15. Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R. Methylation of the RASSF1A gene in human cancers. Biol Chem 2002;383:907-14.
16. Rebbeck TR. Molecular epidemiology of the human glutathione Stransferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
17. Satoh A, Toyota M, Itoh F, Sasaki Y, Suzuki H, Ogi K et al. Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res 2003;63:8606-13.
18. Scolnick D.M., Halazonetis T.D. Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 2000;406:430-5.
19. Shibata Y, Haruki N, Kuwabara Y. CHFR expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis 2002;23:1695-9.
20. Soejima H, Zhao W, Mukai T. Epigenetic silencing of the MGMT gene in cancer. Biochem Cell Biol 2005;83:429-37.
21. Sugawara W, Haruta M, Sasaki F, Watanabe N, Tsunematsu Y, Kikuta A et al. Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma. Pediatr Blood Cancer 2007;49:240-9.
22. Toyota M, Sasaki Y, Satoh A, Ogi K, Kikuchi T, Suzuki H et al. Epigenetic inactivation of CHFR in human tumors. Proc Natl Acad Sci USA 2003;100:7818-23.
23. Vucic EA, Brown CJ, Lam WL. Epigenetics of cancer progression. Pharmacogenomics 2008;9:215-34.
24. Wang JS, Huang T, Su J, Liang F, Wei Z, Liang Y et al. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 2001;10:143-6.
25. Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002;2:29.
26. Zhang YJ, Chen Y, Ahsan H, Lunn RM, Chen SY, Lee PH, Chen CJ, Santella RM. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett 2005;221:135-43.
27. Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res 2003;9:3376-82.